ArticleEClinicalMedicine2024

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study.

Bowen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.